Raloxifene is a medication used to prevent and treat osteoporosis in postmenopausal women. It is also used to reduce the risk of invasive breast cancer in postmenopausal women who have osteoporosis, as well as in postmenopausal women at high risk of invasive breast cancer. Raloxifene works by acting like a selective estrogen receptor modulator (SERM). SERMs are molecules that act like estrogen in some tissues, but block the effects of estrogen in other tissues.
Raloxifene is a medication used to prevent and treat osteoporosis in postmenopausal women and those on glucocorticoids. It is also used to reduce the risk of breast cancer in those at high risk . It is taken by mouth.
Raloxifene is a selective estrogen receptor modulator (SERM), which means it acts like estrogen in some tissues, such as bone, and like an anti-estrogen in others, such as the breast and uterus. This means that it can help to strengthen bones and reduce the risk of breast cancer.
Raloxifene is available under the brand name Evista, among others. It is important to note that Raloxifene should not be used before menopause or to prevent heart disease. If you have any questions about whether Raloxifene is right for you, please talk to your doctor.